Results 241 to 250 of about 8,151 (283)

Refractory Generalised Morphea in Association with Reactive Hypereosinophil Syndrome Successfully Managed with Abatacept.

Indian J Dermatol
Lluch-Galcerá JJ, Casafont-Solé I, Xicoy B, Quer A, Bielsa I.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Extracorporeal Photopheresis

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2009
Photopheresis, originally developed in dermatology, has become a treatment method accepted across various disciplines. A basic knowledge of photomedicine and photobiology is one of the cornerstones of dermatology. Even if photopheresis is used for indications that are not specifically dermatological, e.g.
Mary Darrow, Jeanne Hendrickson, John Roback   +2 more
openaire   +3 more sources

Photopheresis (extracorporeal photochemotherapy)

Photochemical & Photobiological Sciences, 2012
Photopheresis is a form of phototherapy where specialized equipment is used to isolate a leukocyte fraction from the peripheral blood which is then exposed to photoactivated 8-methoxypsoralen and reinfused into the patient. At the time of its invention the treatment was conceptually based on the hypothesis of T cell vaccination, i.e. the observation in
Franz, Trautinger, Ulrike, Just, Robert, Knobler   +2 more
openaire   +2 more sources

[Extracorporeal photopheresis].

Revue medicale suisse, 2019
During the treatment of extracorporeal photopheresis (ECP), white blood cells are collected by apheresis and exposed to ultraviolet A after incubation with 8-methoxypsoralen. Although ECP was first developed for cutaneous T cell lymphoma, it has shown promising efficacy in a number of other serious conditions, like acute and chronic graft-versus-host ...
Aurélie, Hsieh, Begonia, Cortés
openaire   +3 more sources

MINI-PHOTOPHERESIS – A NON-LEUKAPHERESIS BASED EXTRACORPOREAL PHOTOPHERESIS: CLINICAL EXPERIENCE

Pediatria. Journal named after G.N. Speransky, 2021
Extracorporeal photopheresis (ECP) has proven effectiveness for treatment of several diseases, including acute and chronic graft-versus-host disease (GVHD) after allogenic transplantation of hematopoietic blood stem cells. The standard ECP requires leukapheresis to obtain a mononuclear cell fraction. The possibility of using leukapheresis is limited by
I.B. Kumukova, E.E. Kurnikova, M.A. Ilyushina, P.E. Trakhtman   +3 more
openaire   +1 more source

Extracorporeal Photopheresis in Solid Organ Transplantation: Modulating B-cell Responses to Improve Graft Survival

Transplantation Direct
Solid organ transplantation remains the only curative treatment for end-stage organ diseases. A critical aspect of enhancing long-term graft survival is to prevent antibody-mediated rejection caused by donor-specific antibodies (DSAs).
Filipe Nogueira, S. V. van Ham, A. ten Brinke   +2 more
semanticscholar   +1 more source

Collection efficiency of mononuclear cells in offline extracorporeal photopheresis: can processing time be shortened?

Blood transfusion = Trasfusione del sangue, 2023
Background Extracorporeal photopheresis (ECP) is a well-established but lengthy and burdensome cell-based therapy for various diseases such as cutaneous T-cell lymphoma, graft-versus-host disease and organ rejection after transplantation.
Orkan Kartal, N. Lindlbauer, S. Laner-Plamberger, E. Rohde, Fabian Foettinger, Laura Ombres, G. Zimmermann, Cornelia Mrazek, Wanda Lauth, C. Grabmer   +9 more
semanticscholar   +1 more source

Extracorporeal Photopheresis: From Animal Models to Clinical Practice

Transplantation Direct
Extracorporeal photopheresis (ECP) is an immunomodulatory therapy characterized by the exposure of leukocytes to 8-methoxypsoralen and UV light irradiation, followed by reinfusion of the treated cells into the patient.
Inês Morgado, J. M. Vinnakota, R. Zeiser   +2 more
semanticscholar   +1 more source

Extracorporeal Photopheresis in the Treatment of Cardiac Allograft Rejection in the Modern Era: A Single‐Center Experience

Clinical Transplantation
Extracorporeal photopheresis (ECP) has gained recognition as a valuable adjunctive antirejection therapy, particularly in heart‐transplantation (HT) patients at elevated risk for rejection or those experiencing recurrent antibody‐mediated rejection (AMR)
Gal Rubinstein, A. F. Valledor, Cathrine M Moeller, J. Baranowska, Daniel Oren, David Kyung Taek Oh, David Bae, A. Yunis, Dor Lotan, Afsana Rahman, J. Raikhelkar, Justin A Fried, E. DeFilippis, Kevin J Clerkin, Farhana Latif, G. Sayer, N. Uriel   +16 more
semanticscholar   +1 more source

Effect of extracorporeal photopheresis on survival in acute graft versus host disease

Journal of clinical apheresis, 2023
Extracorporeal photopheresis (ECP) is the main non‐pharmacological approach accompanying systemic medical treatments in steroid‐resistant acute or chronic graft versus host disease.
Ahmet Kaya, M. Erkurt, I. Kuku, E. Kaya, İ. Berber, S. Biçim, Emine Hidayet, Salih Cırık, Süleyman Arslan, F. Yağın, A. Sarici   +10 more
semanticscholar   +1 more source